Elevated fibrinogen levels decrease following treatment of acromegaly

Clinical Endocrinology

Volumn 46, Issue 1, 1997, Pages 69-74

  Landin Wilhelmsen, Kerstin ^a   Tengborn, Lilian ^a   Wilhelmsen, Lars ^a   Bengtsson, Bengt Åke ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CHOLESTEROL; CORTISONE ACETATE; ESTROGEN; FIBRINOGEN; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; OCTREOTIDE; SOMATOMEDIN C; TESTOSTERONE; WARFARIN;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STROKE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031017248     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.d01-1743.x     Document Type: Article

References (29)

1. Allain, C.C., Poon, L.S., Chan, C.S.G., Richmond, W. & Fu, P.C. (1974) Enzymatic determinations of total serum cholesterol. Clinical Chemistry, 20, 470-475.
2. Bates, A.S., Van't Hoff, W., Jones, J.M. & Clayton, R.N. (1995) Does treatment of acromegaly affect life expectancy? Metabolism, 44, 1-5.
3. Bengtsson, B.-Å., Edén, S., Ernest, I., Odén, A. & Sjögren, B. (1988) Epidemiology and long-term survival in acromegaly. Acta Medica Scandinavica, 223, 327-335.
4. Davidoff, L. & Cushing, H. (1927) Studies in acromegaly. IV The disturbance of carbohydrate metabolism. Archives of Internal Medicine, 39, 751-779.
5. Dotevall, A., Johansson, S. & Wilhelmsen, L. (1994) Association between fibrinogen and other risk factors for cardiovascular disease in men and women. Results from the Göteborg MONICA survey 1985. Annals of Epidemiology, 4, 369-374.
6. ECAT Angina Pectoris Study Group (1993) ECAT angina pectoris study: baseline associations of haemostatic factor with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. European Heart Journal, 14, 8-17.
7. Forbes, G.B., Gallup, J. & Hursh, J.B. (1961) Estimation of total body fat from potassium-40 content. Science, 133, 101-102.
8. Fossati, P. & Prencipe, L. (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical Chemistry, 2, 33-36.
9. Friedewald, W.T., Levy, R.I. & Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499-502.
10. Hamsten, A., DeFaire, U., Walldius, G., Dahlén, G., Szamosi, A., Landou, C., Blombäck, M. & Wiman, B. (1987) Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet, ii, 3-9.
11. Jansson, J.H., Johansson, B., Boman, K. & Nilsson, T.K. (1991) Hypofibrinolysis in patients with hypertension and elevated cholesterol. Journal of Internal Medicine, 229, 309-316.
12. Johansson, J.-O., Landin, K., Tengborn, L., Rosén, T. & Bengtsson, B.-Å. (1994) High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscleroisis and Thrombosis, 14, 434-437.
13. Lam, K.S.L., Pang, R.W.C., Janus, E.D., Kung, A.W.C. & Wang, C.C.L. (1993) Serum apolipoprotein(a) correlates with growth hormone levels in Chinese patients with acromegaly, Atherosclerosis, 104, 183-188.
14. Landin, K., Stigendal, L., Eriksson, E., Krotkiewski, M., Risberg, B., Tengborn, L. & Smith, U. (1990a) Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism, 39, 1044-1048.
15. Landin, K., Tengborn, L. & Smith, U. (1990b) Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. Journal of Internal Medicine, 227, 273-278.
16. Landin-Wilhelmsen, K., Wilhelmsen, L., Lappas, G., Rosén, T., Lindstedt, G., Lundberg, P.-A. & Bengtsson, B.-Å. (1994) Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clinical Endocrinology, 41, 351-357.
17. Malmberg, K., Båvenholm, P. & Hamsten, A. (1994) Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age. Journal of American College of Cardiology, 24, 592-599.
18. Maxwell, M.H., Waks, A.U., Schroth, P.C., Karam, M. & Dornfeld, L.P. (1982) Error in blood-pressure measurement due to incorrect cuff size in obese patients. Lancet, ii, 33-36.
19. McGuffin, Jr, W.L., Sherman, B.M., Roth, J., Gorden, P., Kahn, R., Roberts, W.C. & Frommer, P.L. (1974) Acromegaly and cardiovascular disorders. A prospective study. Annals of Internal Medicine, 81, 11-18.
20. Melmed, S. (1990) Acromegaly. New England Journal of Medicine, 322, 966-977.
21. Nabarro, J.D. (1987) Acromegaly - a review. Clinical Endocrinology, 26, 481-512.
22. Nikkilä, E.A. & Pelkonen, R. (1975) Serum lipids in acromegaly. Metabolism, 24, 829-838.
23. Petruson, B. & Elfversson, J. (1988) A lateral rhinotomy approach to transsphenoidal hypophysectomy. Clinical Otolaryngology, 13, 251-1258.
24. Schmechel, H. & Krause, V. (1992) Plasma fibrinogen and related factors in subject with diabetic angiopathy. In Fibrinogen: A 'new' cardiovascular risk factor (eds E. Ernst, W. Koenig, G.D.O. Lowe & T.W. Meade) pp. 259-262, Blackwell - M2V, Wien, Austria.
25. Sköldborn, H., Arvidsson, B. & Andersson, M. (1972) A new whole body monitoring laboratory. Acta Radiologica (Suppl. 313), 233-241.
26. Vague, P., Juhan-Vagure, I., Aillaud, M.F., Badier, C., Viard, R., Alessi, M.C. & Collen, D. (1986) Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism, 35, 250-253.
27. von Clauss, A. (1957) Gerinnerungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematologica, 17, 237-246.
28. Wilhelmsen, L., Svärdsudd, K., Korsan-Bengtsen, K., Larsson, B., Welin, L. & Tibblin, G. (1984) Fibrinogen as a risk factor for stroke and myocardial infarction. New England Journal of Medicine, 311, 501-505.
29. Wright, A.D., Hill, D.M., Lowy, C. & Russell Fraser, T. (1970) Mortality in acromegaly. Quarterly Journal of Medicine, 53, 1-16.